Uncharacterized Cannabis Extracts Limited Early Dose–Response Comparisons
Early cannabis experiments could not always connect an administered extract with a known amount of a particular cannabinoid. A historical chapter by Gabriel Nahas identified this preparation problem before presenting its toxicology arguments. That limitation matters when comparing older reports numerically.
A named extract was not a complete chemical description
The chapter explains that early investigators lacked the pure reference compounds later used to characterize cannabinoid effects. Preparations could therefore differ in composition and potency even when described with similar terminology.
The concern is about comparability, rather than whether every early observation was meaningless. A qualitative response can be real while its relationship to a known THC dose remains uncertain.
Purified THC and plant material posed different questions
Nahas also distinguished experiments with isolated cannabinoids from those using cannabis extracts or smoke. Extract constituents and combustion products were not represented fully by an experiment with one purified compound.
Consequently, equal masses of two preparations cannot be assumed to represent equal amounts of the same active material. Nor can an injected amount of purified THC be treated as a measured absorbed amount from smoking.
Use older evidence with its preparation limits
A quantitative comparison needs the compound, formulation, route and basis of the reported dose. When those details are missing, supplying a precise modern THC equivalent would create information the source did not establish.
This is an assessment of historical research design, not a present-day product-safety conclusion. The chapter’s useful caution is that chemical identity and exposure characterization must precede a confident dose–effect comparison.
Related: Separating cannabis exposure and impairment.
Research cited
Gabriel G. Nahas. Marihuana: Toxicity and Tolerance. Historical book chapter, pp. 16–36.
